| 1 | Percentage of correspondence responded to within the month | CVM | Office of the Center Director | Active | Program Measures |  |
| 2 | Total number of correspondence received within the month | CVM | Office of the Center Director | Active | Program Measures |  |
| 3 | Total number of correspondence responded to within the month | CVM | Office of the Center Director | Active | Program Measures |  |
| 4 | Percentage of international meeting requests received by CVM from others and that are held at CVM on a monthly basis | CVM | Office of the Center Director | Active | Program Measures |  |
| 5 | Percentage of meeting requests received by CVM from others and that are held/hosted by others on a monthly basis | CVM | Office of the Center Director | Active | Program Measures |  |
| 6 | Percentage of bilateral meetings conducted in the quarter | CVM | Office of the Center Director | Active | Program Measures |  |
| 7 | Percentage of trilateral meetings conducted in the quarter | CVM | Office of the Center Director | Active | Program Measures |  |
| 8 | Percentage of WTO SPS notifications commented on within 15 days of date assigned | CVM | Office of the Center Director | Active | Program Measures |  |
| 9 | Percentage of PMAPs established for new CVM employees completed on-time, within 30 days of arrival, during the month | CVM | Office of Management | Active | Program Measures |  |
| 10 | Strategic Human Capital Plan Project | CVM | Office of Management | Completed | Key Projects |  |
| 11 | Resource Planning for Foods Program Project | CVM | Office of Management | Completed | Key Projects |  |
| 12 | Total number of training events offered during the month | CVM | Office of Management | Completed | Key Center Director Measures |  |
| 13 | Total percentage of OM employees who attended training events during the month | CVM | Office of Management | Completed | Key Center Director Measures |  |
| 14 | Percentage of CVM employees who reported 100% of their time during the reporting period | CVM | Office of Management | Completed | Program Measures |  |
| 15 | Competency Models Project | CVM | Office of Management | Completed | Key Projects |  |
| 16 | Workforce Initiative Planning Strategies Project - Workforce Profiles | CVM | Office of Management | Completed | Key Projects |  |
| 17 | Workforce Initiative Planning Strategies Project - Attrition Projection Models | CVM | Office of Management | Completed | Key Projects |  |
| 18 | Pioneer and Generic Animal Drug User Fees Renegotiations | CVM | Office of Management | Completed | Key Projects |  |
| 19 | Percentage of designation submissions reviewed and acted on within 100 days | CVM | Office of Minor Use and Minor Species Animal Drug Development | Active | Program Measures |  |
| 20 | Percentage of INAD study submissions reviewed within the month that were acted on within 180 days after the submission date | CVM | Office of New Animal Drug Evaluation | Active | Program Measures |  |
| 21 | Percentage of INAD submissions consisting of protocols without substantial data reviewed and acted on within the month where the sponsor was notified of the Agency's decision on or before day 50 | CVM | Office of New Animal Drug Evaluation | Active | Program Measures |  |
| 22 | Percentage of manufacturing supplemental new animal drug applications and reactivations of such supplemental applications reviewed within the month that were acted on within 120 days after the submission date | CVM | Office of New Animal Drug Evaluation | Active | Program Measures |  |
| 23 | Percentage of non-administrative original ANADAs and reactivations of such applications completed on time | CVM | Office of New Animal Drug Evaluation | Active | Program Measures |  |
| 24 | Percentage of manufacturing supplemental ANADAs and reactivations of such supplemental applications completed on time | CVM | Office of New Animal Drug Evaluation | Active | Program Measures |  |
| 25 | Percentage of JINAD study submissions completed on time | CVM | Office of New Animal Drug Evaluation | Active | Program Measures |  |
| 26 | Percentage of JINAD submissions consisting of protocols without substanial data completed on time | CVM | Office of New Animal Drug Evaluation | Active | Program Measures |  |
| 27 | Percentage of administrative ANADAs (ANADAs submitted after all scientific decisions have been made in the JINAD process) completed on time | CVM | Office of New Animal Drug Evaluation | Active | Program Measures |  |
| 28 | Number of pre-AGDUFA generic new animal drug submissions reviewed and completed during the month | CVM | Office of New Animal Drug Evaluation | Completed | Program Measures |  |
| 29 | Number of pending pre-AGDUFA submissions to review at the end of the month | CVM | Office of New Animal Drug Evaluation | Completed | Program Measures |  |
| 30 | Nanotechnology Project - Develop Policies and Procedures | CVM | Office of New Animal Drug Evaluation | Completed | Key Projects |  |
| 31 | Total number of training events offered during the month | CVM | Office of New Animal Drug Evaluation and Office of Minor Use and Minor Species Animal Drug Development | Completed | Key Center Director Measures |  |
| 32 | Total percentage of ONADE and OMUMS employees who attended training events during the month | CVM | Office of New Animal Drug Evaluation and Office of Minor Use and Minor Species Animal Drug Development | Completed | Key Center Director Measures |  |
| 33 | Linkages between Gene and Protein Expression and Chemical Exposures Measures - Determine the impact of canine MDR-1 mutations on therapeutic effectiveness and adverse reactions to veterinary drugs | CVM | Office of Research | Active | Program Measures |  |
| 34 | Integrated Techniques, Approaches, and Technologies for the Characterization of Genomic and Proteomic Biomarkers Measures – Development of techniques to analyze biological specimens for biomarkers of disease or therapeutic response | CVM | Office of Research | Active | Program Measures |  |
| 35 | NARMS Measures - Develop better molecular techniques for the characterization of isolates in foodborne pathogens | CVM | Office of Research | Active | Program Measures |  |
| 36 | NARMS Data Management Systems Project | CVM | Office of Research | Completed | Key Projects |  |
| 37 | Updating Obsolete Regulatory Residue Methods Project | CVM | Office of Research | Active | Key Projects |  |
| 38 | Total number of training events offered during the month | CVM | Office of Research | Completed | Key Center Director Measures |  |
| 39 | Total percentage of OR employees who attended training events during the month | CVM | Office of Research | Completed | Key Center Director Measures |  |
| 40 | Percentage of electronic ADE submissions | CVM | Office of Surveillance and Compliance | Active | Program Measures |  |
| 41 | Number of warning letters received, completed and pending | CVM | Office of Surveillance and Compliance | Active | Program Measures |  |
| 42 | Average number of business days for CVM to complete the review of warning letters from ORA districts and number of OSC staff reviewing warning letters during the month | CVM | Office of Surveillance and Compliance | Active | Program Measures |  |
| 43 | ADE Reports System Project | CVM | Office of Surveillance and Compliance | Active | Key Projects |  |
| 44 | MNVP Project | CVM | Office of Surveillance and Compliance | Completed | Key Projects |  |
| 45 | Development of XML Files for Releasable CVM ADE Data | CVM | Office of Surveillance and Compliance | Active | Key Projects |  |
| 46 | Total number of training events during the month | CVM | Office of Surveillance and Compliance | Completed | Key Center Director Measures |  |
| 47 | Total percentage of OSC employees who attended training events during the month | CVM | Office of Surveillance and Compliance | Completed | Key Center Director Measures |  |